All In MedTech

Device Trial Radar · NCT04984499

In Vivo Clinical Investigation of the Safety and Performance of Dental Implants TBR® Tissue Level Z1

In Vivo Clinical Investigation of the Safety and Performance of Dental Implants TBR® Tissue Level Z1 With Ceramic Emergence

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

156

Actual

Start

Oct 5, 2021

Primary completion

Sep 2027

Study completion Dec 2027

Sponsor

Lead sponsor
Sudimplant SAS - Groupe TBRNot on our public-company list
Sponsor type
Industry
First posted
Jul 30, 2021

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Partial or total edentulousness has a significant impact on quality of life both functionally and aesthetically. TBR® Tissue Level Z1 Implants allow the patient to prevent bone resorption and maintain facial tissue and musculature support. At the functional level, the patient who benefits from implant treatment regains normal masticatory function with all the benefits on the quality of life that this can bring him. Due to the osseointegration of the implant and the biocompatibility of the materials used, the implant treatment remains effective in the long term and makes it possible to maintain the aesthetics of the smile.

Conditions

  • Edentulous Mouth

Interventions

  • Dental implantDevice

    The procedure used to accomplish its intended use is as follows : The recipient implant site is prepared using a drilling sequence, then the implant is placed at the crestal level with a cover screw to allow the tissues healing. After this healing phase, the final prosthesis will be loaded on the implant.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. the success rate of tissue integration of the implantTime frame: 15 years after implantation

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Cabinet du Dr ALLOUCHE

    Montpellier, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.